FDA Approves BLA761530 (LUMVOA) from Viridian Therapeutics
The FDA has approved BLA761530, known as LUMVOA, submitted by Viridian Therapeutics.
Company
Pharmaceutical intelligence for Viridian Therapeutics with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
The FDA has approved BLA761530, known as LUMVOA, submitted by Viridian Therapeutics.
No signals indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.